Login to Your Account

Legochem Biosciences Inc. (LCB) boasts an intuitive name, hearkening to the use of Lego-like scaffolds to enable the discovery of drug candidates. But the platform is more than a toy for scientists.
Shares of Immunovaccine Inc. (TSX:V:IMV) gained 14.4 percent Monday, to close at C$1.11 (US$1.01), after the Halifax, Nova Scotia-based company reported that monkeys dosed with an Ebola vaccine employing its Depovax formulation technology survived exposure to a lethal dose of the virus in a challenge study performed by the National Institute of Allergy and Infectious Diseases (NIAID).
SHANGHAI – Newly minted Zai Lab Ltd., of Shanghai, has made its eagerly awaited debut announcement, obtaining global rights to two Sanofi SA preclinical compounds for chronic respiratory diseases.
More Newco News Headlines

Cast Your Vote

Has biotech’s bubble burst?: